Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 3
    1
    33%
    Phase 2
    1
    33%
    Phase 4
    1
    33%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    2

    Late Stage

    Phase Distribution3 total trials
    Phase 2Efficacy & side effects
    1(33.3%)
    Phase 3Large-scale testing
    1(33.3%)
    Phase 4Post-market surveillance
    1(33.3%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Other(1)

    Detailed Status

    Completed2
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 21 (33.3%)
    Phase 31 (33.3%)
    Phase 41 (33.3%)

    Trials by Status

    completed267%
    unknown133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    completedphase_4

    Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis

    NCT00987324
    completedphase_3

    A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent

    NCT01622075
    unknownphase_2

    Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

    NCT00998439

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT00987324Phase 4

    Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis

    Completed
    NCT01622075Phase 3

    A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent

    Completed
    NCT00998439Phase 2

    Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

    Unknown

    All 3 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    3